Skip to main navigation Skip to search Skip to main content

Dual anti-angiogenic and cytotoxic properties of ruthenium(III) complexes containing pyrazolato and/or pyrazole ligands

  • Raymond Wai-Yin Sun
  • , Miro Fei-Yeung Ng
  • , Ella Lai-Ming Wong
  • , Jingfei Zhang
  • , Stephen Sin-Yin Chui
  • , Lam Shek
  • , Tai-Chu Lau
  • , Chi-Ming Che

    Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

    Abstract

    An oxo-bridged diruthenium(III) complex containing pyrazolato and pyrazole ligands is stable against ascorbic-acid reduction, induces apoptosis (60%, 48 h) against HeLa cells at 10 μM level and exhibits promising anti-angiogenic activity at its sub-cytotoxic concentrations. Other mononuclear ruthenium(III) complexes containing pyrazole ligands [Ru(pz)4X2] + exhibit dual anti-angiogenic and cytotoxic properties. © The Royal Society of Chemistry 2009.
    Original languageEnglish
    Pages (from-to)10712-10716
    JournalDalton Transactions
    Issue number48
    DOIs
    Publication statusPublished - 2009

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Dual anti-angiogenic and cytotoxic properties of ruthenium(III) complexes containing pyrazolato and/or pyrazole ligands'. Together they form a unique fingerprint.

    Cite this